Assessment of Nitazoxanide Loaded on Silver nanoparticles Efficacy on Treatment of Murine Model of Chronic Toxoplasmosis

Bibliographic Information
Authors: Saleh M.H.; Nagaty I.M.; Zalat R.S.; Ahmed K.A.; Yaseen D.I.; Abdelhameed R.M.; Kishik S.M.
Journal: Benha Medical Journal
Publisher: Benha University Faculty of Medicine
Publication Date: 2021
Volume / Issue: Volume 38
ISSN: 1110208X
DOI: 10.21608/bmfj.2021.58655.1372
Scopus: View on Scopus
Document Type: Article
Authors and Affiliations
Saleh M.H., Department of Parasitology, Faculty of Medicine, Benha University, Egypt; Nagaty I.M., Department of Parasitology, Faculty of Medicine, Benha University, Egypt; Zalat R.S., Department of Parasitology, Theodore Bilharz Research Institute, Egypt; Ahmed K.A., Egypt. Department of Parasitology, Faculty of Veterinary Medicine, Cairo University, Egypt; Yaseen D.I., Department of Parasitology, Faculty of Medicine, Benha University, Egypt; Abdelhameed R.M., Department of Applied Organic Chemistry, Chemical Industries Research Division, National Research Centre, Egypt; Kishik S.M., Department of Parasitology, Faculty of Medicine, Benha University, Egypt
Abstract
Background: Silver nanoparticles (AgNPs) can be used as vehicles to transport drug molecules to target zones and there by improve their therapeutical efficacy. Aim: The aim of the present work was to assess the effect of nitazoxanide loaded on silver nanoparticles (AgNps) in treatment of chronic toxoplasmosis in mice. Materials and methods: Mice were infected with T. gondii Me49 non-virulent strain and divided into 2 subgroups according to the time of starting treatment, and each subgroup sub divided into 7 groups. GI: Non infected-non-treated, GII: Infected non-treated mice, GIII: Infected and treated by spiramycin, GIV: Infected and treated by nitazoxanide, GVa: Infected and treated by nitazoxanide loaded on silver nanoparticles, GVb: Infected and treated by nanosilver only, GVI: infected and treated by combination of nitazoxanide and spiramycin, GVII: infected and treated by combination of nitazoxanide loaded on silver nanoparticles and spiramycin. Effect of treatment was assessed by counting the number of T. gondii brain cysts, histopathology and scanning electron microscopy. Results: Nitazoxanide loaded on AgNps significantly reduced the number of T. gondii brain tissue cysts and improved the inflammatory and pathological changes in brain tissue sections in treated groups as compared to the other groups. It also affects the normal architecture and size of tissue cysts in brain. Conclusion: Nitazoxanide loaded on AgNps proved their effectiveness against the experimental chronic Toxoplasma infection. © 2021, Benha University Faculty of Medicine. All rights reserved.
Keywords
Nitazoxanide (NTZ); Phosphate puffer solution (PBS); Silver Nanoparticles (AgNps); Toxoplasmosis
Citation Information
Scopus Citations: 0
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
